6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
19m ago	UPDATED NOTICE REGARDING THE PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS
19m ago	London's Top Restaurants Named at Inaugural OpenTable Awards, Including New 'Icons'
19m ago	eDreams ODIGEO Exceeds Subscriber Growth Target by 5% and Reaches 7.9 Million Prime Members
44m ago	Smithfield Foods Reports Record First Quarter Fiscal 2026 Results
44m ago	ETC’s Aerospace and Commercial/Industrial Units Awarded Contracts of Approximately $37 Million

About

Heron Therapeuti (NASDAQ:HRTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

Financials

Revenue

$154.9 M

Market Cap

$150.68 M

EPS

-0.12

Community Chat

Ask AI